IN2012DN03368A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03368A IN2012DN03368A IN3368DEN2012A IN2012DN03368A IN 2012DN03368 A IN2012DN03368 A IN 2012DN03368A IN 3368DEN2012 A IN3368DEN2012 A IN 3368DEN2012A IN 2012DN03368 A IN2012DN03368 A IN 2012DN03368A
- Authority
- IN
- India
- Prior art keywords
- fragment
- fusion
- variant
- derivative
- inflammation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0916578.8A GB0916578D0 (en) | 2009-09-22 | 2009-09-22 | Polypeptides and uses thereof |
PCT/GB2010/001781 WO2011036445A2 (en) | 2009-09-22 | 2010-09-22 | Polypeptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN03368A true IN2012DN03368A (es) | 2015-10-23 |
Family
ID=41278086
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2981DEN2012 IN2012DN02981A (es) | 2009-09-22 | 2010-09-21 | |
IN3368DEN2012 IN2012DN03368A (es) | 2009-09-22 | 2010-09-22 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2981DEN2012 IN2012DN02981A (es) | 2009-09-22 | 2010-09-21 |
Country Status (12)
Country | Link |
---|---|
US (2) | US9169315B2 (es) |
EP (2) | EP2480244A1 (es) |
JP (2) | JP2013505030A (es) |
CN (2) | CN102655874B (es) |
AU (2) | AU2010299630A1 (es) |
BR (2) | BR112012006502A2 (es) |
CA (2) | CA2774288A1 (es) |
EA (1) | EA201200515A1 (es) |
GB (1) | GB0916578D0 (es) |
IN (2) | IN2012DN02981A (es) |
MX (1) | MX2012003425A (es) |
WO (2) | WO2011036444A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6491880B2 (ja) * | 2011-08-23 | 2019-03-27 | シナプス・ビー.ブイ.Synapse B.V. | 異物表面との接触による血液凝固系の活性化の熱安定性阻害剤 |
RU2476231C1 (ru) * | 2011-10-11 | 2013-02-27 | Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации | Способ купирования некроза краев кожи послеоперационной раны после эндопротезирования голеностопного сустава |
GB2500184A (en) * | 2012-03-12 | 2013-09-18 | Ximmune Ab | Polypeptide derived from helix A of heparin cofactor II |
CN104292309B (zh) * | 2014-09-29 | 2017-04-12 | 广西中医药大学 | 一种小分子多肽 |
WO2016104436A1 (ja) * | 2014-12-22 | 2016-06-30 | 国立大学法人 岡山大学 | サイトカインストーム抑制剤 |
RU2606836C2 (ru) * | 2015-03-12 | 2017-01-10 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Антикоагулянтный, антитромбоцитарный и фибриндеполимеризационный комплекс на основе гепарина, способ его получения и применение |
RU2610433C1 (ru) * | 2016-02-17 | 2017-02-10 | Людмила Анисимовна Ляпина | Антикоагулянт |
CN107875372A (zh) * | 2017-12-20 | 2018-04-06 | 辽宁师范大学 | 重组肽rLj‑112在制备协同肝素抗凝药物中的应用 |
CN108338163A (zh) * | 2018-03-28 | 2018-07-31 | 陈太师 | 一种持效型杀菌灭藻剂的制备方法 |
EP3808362A4 (en) * | 2018-05-31 | 2022-03-09 | National University Corporation Okayama University | REACTIVE OXYGEN PRODUCTION INHIBITORS AND/OR SCAVENGING PROMOTERS |
JP7340862B2 (ja) * | 2018-06-28 | 2023-09-08 | 国立大学法人 岡山大学 | 好中球貪食能増強剤 |
JP2021535370A (ja) * | 2018-08-16 | 2021-12-16 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 心房細動および抗凝固療法の評価における循環tfpi−2(組織因子経路阻害剤2) |
CN109432513B (zh) * | 2018-12-12 | 2021-03-23 | 中国医科大学 | 一种具有抗血栓再形成功能的生物材料及其制备方法 |
US11904000B2 (en) | 2019-05-06 | 2024-02-20 | Brown University | Compositions and methods to enhance cutaneous wound healing |
JP2023526880A (ja) * | 2020-05-26 | 2023-06-26 | ウニヴェルシテーツメディツィン・デア・ヨハネス・グーテンベルク-ウニヴェルシテート・マインツ | コロナウイルス感染症および関連する凝固障害を処置するための方法および組成物 |
CN114886116B (zh) * | 2022-03-18 | 2023-11-21 | 广东丸美生物技术股份有限公司 | 一种调理育龄女性健康的组合物及其制备方法和饮料及应用 |
CN116836233B (zh) * | 2023-08-31 | 2023-11-14 | 中国农业大学 | 抗炎活性多肽及其应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
US5118793A (en) * | 1989-10-20 | 1992-06-02 | Washington University | Modified heparin cofactor II |
US5102995A (en) * | 1989-10-20 | 1992-04-07 | Washington University | Dna encoding modified heparin cofactor ii |
US5643872A (en) | 1989-10-23 | 1997-07-01 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
AU1873092A (en) * | 1991-04-09 | 1992-11-17 | Brigham And Women's Hospital | Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques |
US6008058A (en) | 1993-06-18 | 1999-12-28 | University Of Louisville | Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis |
US5589359A (en) | 1994-08-05 | 1996-12-31 | Chiron Corporation | Chimeric proteins |
US5712247A (en) * | 1995-02-21 | 1998-01-27 | University Of North Carolina | Use of lactoferrin to modulate and/or neutralize heparin activity |
CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
JPH09176040A (ja) * | 1995-12-27 | 1997-07-08 | Green Cross Corp:The | ヘパリンコファクターiiの医薬用途 |
US6946439B2 (en) * | 1997-02-06 | 2005-09-20 | Entre Med, Inc. | Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments |
WO1999043810A1 (en) * | 1998-02-27 | 1999-09-02 | The University Of North Carolina At Chapel Hill | Mutant heparin cofactor ii |
WO2001036632A2 (en) * | 1999-11-17 | 2001-05-25 | Compugen Ltd. | Variants of alternative splicing |
MXPA04000564A (es) * | 2001-07-20 | 2005-02-17 | Univ Zuerich | Composiciones y metodos para uso de agentes bioactivos derivados de aminoacidos sulfatados y sulfonados. |
GB0131112D0 (en) | 2001-12-31 | 2002-02-13 | Univ London Pharmacy | Block copolymers |
ATE522601T1 (de) * | 2002-05-31 | 2011-09-15 | Univ Utah Res Found | Varianten von antithrombin iii |
AU2003294401C1 (en) * | 2002-11-22 | 2008-09-18 | Ansun Biopharma, Inc. | Broad spectrum anti-viral therapeutics and prophylaxis |
GB0316294D0 (en) | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
JP2007501605A (ja) | 2003-08-08 | 2007-02-01 | ジェノバ・リミテッド | 心血管疾患に関連する分泌ポリペプチド種 |
CN101426520A (zh) * | 2004-03-17 | 2009-05-06 | 诺华疫苗和诊断公司 | 通过给予组织因子途径抑制剂(tfpi)治疗社区获得性重症肺炎 |
US20050261241A1 (en) * | 2004-05-19 | 2005-11-24 | Celsus Biopharmaceuticals, Inc. | Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses |
US20090214506A1 (en) * | 2005-05-06 | 2009-08-27 | Novartis Ag | Use of TFPI to Treat Severe Bacterial Infections |
BRPI0613676A2 (pt) * | 2005-07-22 | 2011-01-25 | Novartis Ag | polipeptìdeo, seu uso e composição farmacêutica compreendendo o mesmo |
JP5770966B2 (ja) * | 2005-12-29 | 2015-08-26 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Tfpi−2の変異体クニッツドメインiに関連した方法および組成物 |
SI1981519T1 (en) * | 2005-12-29 | 2018-05-31 | Dyax Corp. | INHIBITION PROTEAZE |
CA2637221A1 (en) * | 2006-02-10 | 2007-08-16 | Dermagen Ab | Novel antimicrobial peptides and use thereof |
MX2009010997A (es) * | 2007-04-13 | 2009-11-02 | Catalyst Biosciences Inc | Polipeptidos modificados con el factor vii y usos de los mismos. |
EP2173327A2 (en) * | 2007-07-24 | 2010-04-14 | Nexbio, Inc. | Technology for the preparation of microparticles |
-
2009
- 2009-09-22 GB GBGB0916578.8A patent/GB0916578D0/en not_active Ceased
-
2010
- 2010-09-21 MX MX2012003425A patent/MX2012003425A/es not_active Application Discontinuation
- 2010-09-21 US US13/497,006 patent/US9169315B2/en not_active Expired - Fee Related
- 2010-09-21 EA EA201200515A patent/EA201200515A1/ru unknown
- 2010-09-21 AU AU2010299630A patent/AU2010299630A1/en not_active Abandoned
- 2010-09-21 JP JP2012530325A patent/JP2013505030A/ja active Pending
- 2010-09-21 CN CN201080052695.8A patent/CN102655874B/zh not_active Expired - Fee Related
- 2010-09-21 BR BR112012006502A patent/BR112012006502A2/pt not_active IP Right Cessation
- 2010-09-21 CA CA2774288A patent/CA2774288A1/en not_active Abandoned
- 2010-09-21 EP EP10777056A patent/EP2480244A1/en not_active Withdrawn
- 2010-09-21 IN IN2981DEN2012 patent/IN2012DN02981A/en unknown
- 2010-09-21 WO PCT/GB2010/001780 patent/WO2011036444A1/en active Application Filing
- 2010-09-22 IN IN3368DEN2012 patent/IN2012DN03368A/en unknown
- 2010-09-22 US US13/497,195 patent/US20120189673A1/en not_active Abandoned
- 2010-09-22 CN CN2010800527096A patent/CN102639556A/zh active Pending
- 2010-09-22 BR BR112012006501A patent/BR112012006501A8/pt not_active IP Right Cessation
- 2010-09-22 AU AU2010299631A patent/AU2010299631A1/en not_active Abandoned
- 2010-09-22 JP JP2012530326A patent/JP2013505286A/ja not_active Abandoned
- 2010-09-22 EP EP10777057A patent/EP2480564A2/en not_active Withdrawn
- 2010-09-22 WO PCT/GB2010/001781 patent/WO2011036445A2/en active Application Filing
- 2010-09-22 CA CA2774296A patent/CA2774296A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA201200515A1 (ru) | 2012-10-30 |
IN2012DN02981A (es) | 2015-07-31 |
CA2774296A1 (en) | 2011-03-31 |
US9169315B2 (en) | 2015-10-27 |
AU2010299631A1 (en) | 2012-05-03 |
CN102655874B (zh) | 2015-06-10 |
GB0916578D0 (en) | 2009-10-28 |
WO2011036445A3 (en) | 2011-09-01 |
EP2480244A1 (en) | 2012-08-01 |
WO2011036445A2 (en) | 2011-03-31 |
CN102639556A (zh) | 2012-08-15 |
CN102655874A (zh) | 2012-09-05 |
BR112012006501A2 (pt) | 2016-08-16 |
AU2010299630A1 (en) | 2012-04-26 |
AU2010299630A2 (en) | 2012-05-03 |
JP2013505286A (ja) | 2013-02-14 |
JP2013505030A (ja) | 2013-02-14 |
WO2011036444A4 (en) | 2011-06-23 |
US20120189673A1 (en) | 2012-07-26 |
BR112012006501A8 (pt) | 2017-07-11 |
WO2011036444A1 (en) | 2011-03-31 |
CA2774288A1 (en) | 2011-03-31 |
EP2480564A2 (en) | 2012-08-01 |
US20120177715A1 (en) | 2012-07-12 |
MX2012003425A (es) | 2012-10-09 |
BR112012006502A2 (pt) | 2016-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN03368A (es) | ||
WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
PH12019500694A1 (en) | Factor viii compositions and methods of making and using the same | |
NZ602943A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
MX362028B (es) | Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos. | |
MX2009012650A (es) | Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos. | |
WO2010115998A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders | |
MX2009002816A (es) | Proteinas de fusion de albumina. | |
EP2470559A4 (en) | COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING THEM | |
WO2007104529A3 (en) | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
WO2011123813A3 (en) | Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same | |
EA201190326A8 (ru) | Полипептиды гормона роста и способы их получения и применения | |
WO2011123830A3 (en) | Alpha 1-antitrypsin compositions and methods of making and using same | |
RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
MX2019002345A (es) | Moleculas artificiales de acido nucleico para la expresion mejorada de proteina o peptido. | |
TNSN08064A1 (en) | Albumin fusion proteins | |
TW201129379A (en) | Anti-Orai1 antigen binding proteins and uses thereof | |
BR112014024282A2 (pt) | anticorpos ligantes ao receptor b1 da bradicinina | |
WO2009001260A3 (en) | Cosmetic use of apolipoprotein d type proteins | |
WO2011135222A3 (fr) | Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles | |
WO2010103515A3 (en) | Compositions and methods for prevention and treatment of neurodegenerative diseases | |
BR112013022557A2 (pt) | ligantes de peptídeo composições de polipeptídeo e métodos para uso dos mesmos | |
WO2012029061A3 (en) | POLYPEPTIDES DERIVED FROM α-1 ANTITRYPSIN AND METHODS OF USE THEREOF | |
WO2010078469A3 (en) | Sand fly salivary proteins as novel factor xa inhibitors and methods of use | |
MX2016002556A (es) | Métodos y composiciones para el tratamiento de patologías del tejido de cartílago y disco. |